Evidence map›Paper›PMID 32191637›Full record

ArticleJCI insight2020

Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice.

Tatjana Josefs, Tessa J Barrett, Emily J Brown, Alexandra Quezada, Xiaoyun Wu, Maud Voisin, Jaume Amengual, Edward A Fisher

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 213 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Early atherogenesis: In search of etiology.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  9. Article
  10. Article
  11. MMP8 Promotes NETosis in Gestational Diabetes Mellitus.Antioxidants (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tatjana JosefsDivision of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York, USA.
Tessa J BarrettDivision of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York, USA.
Emily J BrownDivision of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York, USA.
Alexandra QuezadaDivision of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York, USA.
Xiaoyun WuDepartment of Food Science and Human Nutrition, University of Illinois, Urbana-Champaign, Illinois, USA.
Maud VoisinDepartment of Microbiology, New York University School of Medicine, New York, New York, USA.
Jaume AmengualDepartment of Food Science and Human Nutrition, University of Illinois, Urbana-Champaign, Illinois, USA.
Edward A FisherDivision of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York, USA.
New York University · USUniversity of Illinois Urbana-Champaign · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
Resolving Macrophage Inflammation in Atherosclerotic Plaques and Other Sites in Insulin ResistanceP01HL131481 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANN MARIE SCHMIDT · 2017 to 2026
$27.3M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2008 to 2019
$23.5M
Molecular Regulation of Atherosclerosis Regression - RenewalR01HL084312 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A · 2006 to 2024
$11.4M
Diabetes-Mediated Effects on Myeloid Precursors and Vascular ComplicationsR01DK095684 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A, GOLDBERG, IRA J · 2012 to 2016
$2.7M
HDL and atherosclerosis regressionR01HL129433 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A, MOORE, KATHRYN J · 2016 to 2019
$2.4M
To study the role of the low-density lipoprotein receptor on carotenoid biodistribution and excretionR01HL147252 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI AMENGUAL TERRASA, JAIME · 2019 to 2023
$2.1M
Regulation of LXR alpha by glucose & cholesterol in diabetes & atherosclerosisR01HL117226 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A, GARABEDIAN, MICHAEL J. · 2014 to 2017
$2.1M
NCI NIH HHS P30 CA016087NHLBI NIH HHS P01 HL092969NHLBI NIH HHS P01 HL131481NHLBI NIH HHS R01 HL084312NHLBI NIH HHS R01 HL117226NHLBI NIH HHS R01 HL129433NHLBI NIH HHS R01 HL147252NIDDK NIH HHS R01 DK095684
6 · The paper itself

Abstract

Neutrophil extracellular traps (NETs) promote inflammation and atherosclerosis progression. NETs are increased in diabetes and impair the resolution of inflammation during wound healing. Atherosclerosis resolution, a process resembling wound healing, is also impaired in diabetes. Thus, we hypothesized that NETs impede atherosclerosis resolution in diabetes by increasing plaque inflammation. Indeed, transcriptomic profiling of plaque macrophages from NET+ and NET- areas in low-density lipoprotein receptor-deficient (Ldlr-/-) mice revealed inflammasome and glycolysis pathway upregulation, indicating a heightened inflammatory phenotype. We found that NETs declined during atherosclerosis resolution, which was induced by reducing hyperlipidemia in nondiabetic mice, but they persisted in diabetes, exacerbating macrophage inflammation and impairing resolution. In diabetic mice, deoxyribonuclease 1 treatment reduced plaque NET content and macrophage inflammation, promoting atherosclerosis resolution after lipid lowering. Given that humans with diabetes also exhibit impaired atherosclerosis resolution with lipid lowering, these data suggest that NETs contribute to the increased cardiovascular disease risk in this population and are a potential therapeutic target.

Indexed as

AnimalsAtherosclerosisDiabetes Mellitus, ExperimentalExtracellular TrapsInflammationMacrophagesMiceMice, KnockoutAtherosclerosisCardiologyDiabetesInflammation

Identifiers

PMID32191637
PMCPMC7205252
OpenAlexW3011225388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.